Joseph T Hanlon1,2,3,4, Subashan Perera1,5, Paul J Drinka6, Christopher J Crnich7,8, Steven J Schweon9, Michele Klein-Fedyshin10, Charles B Wessel10, Stacey Saracco1, Gulsum Anderson1, Mary Mulligan11, David A Nace1. 1. Division of Geriatric Medicine, Department of Medicine (Geriatrics), University of Pittsburgh, Pittsburgh, Pennsylvania. 2. Department of Pharmacy and Therapeutics, School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania. 3. Geriatric Research Education and Clinical Center (GRECC), Veterans Affairs Pittsburgh Healthcare System (VAPHS), Pittsburgh, Pennsylvania. 4. Center for Health Equity Research and Promotion (CHERP), VAPHS, Pittsburgh, Pennsylvania. 5. Department of Biostatistics, School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania. 6. Divisions of Internal Medicine and Geriatric Medicine, University of Wisconsin, Madison, Wisconsin. 7. Infectious Disease, Department of Medicine, School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin. 8. William S. Middleton Veterans Administration Medical Center, Madison, Wisconsin. 9. Infection Prevention Consultant, Saylorsburg, Pennsylvania. 10. Health Sciences Library System, University of Pittsburgh, Pittsburgh, Pennsylvania. 11. AMDA, The Society of Post-Acute and Long-Term Care Medicine, Columbia, Maryland.
Abstract
OBJECTIVE: To establish consensus recommendations for empirical treatment of uncomplicated cystitis with anti-infectives in noncatheterized older nursing home residents to be implemented in the Improving Outcomes of UTI Management in Long-Term Care Project (IOU) funded by the Agency for Healthcare Research and Quality. DESIGN: Two-round modified Delphi survey. PARTICIPANTS: Expert panel of 19 clinical pharmacists. MEASUREMENTS: Comprehensive literature search and development/review/edit of draft survey by the investigative group (one geriatric clinical pharmacist, two geriatric medicine physicians, and one infectious disease physician). The expert panel members rated their agreement with each of 31 recommendations for drugs of choice, dosing medications at various levels of renal function, drug-drug interactions to avoid, and duration of therapy by sex on a 5-point Likert scale (1 = strongly disagree to 5 = strongly agree). Consensus agreement was defined as a lower 95% confidence limit of 4.0 or higher for the recommendation-specific mean score. RESULTS: The response rate was 95% for the first round, and three recommendations achieved consensus (dosing for nitrofurantoin and trimethoprim/sulfamethoxazole in those without chronic kidney disease, and drug-drug interaction between trimethoprim/sulfamethoxazole and warfarin). In the second round, 90% responded and reached consensus on an additional eight recommendations (two for nitrofurantoin or trimethoprim/sulfamethoxazole as initial drugs of choice, three for dosing ciprofloxacin, nitrofurantoin, and trimethoprim/sulfamethoxazole at various levels of chronic kidney disease, and three drug-drug interactions to avoid: trimethoprim/sulfamethoxazole with phenytoin and ciprofloxacin with theophylline or with tizanidine). CONCLUSION: An expert panel of clinical pharmacists was able to reach consensus on a set of recommendations for the empirical treatment of cystitis with oral anti-infective medications in older nursing home residents. The recommendations were incorporated into a treatment algorithm for uncomplicated cystitis in noncatheterized nursing home residents and used in educational materials for health professionals in an ongoing controlled intervention study. J Am Geriatr Soc 67:539-545, 2019.
OBJECTIVE: To establish consensus recommendations for empirical treatment of uncomplicated cystitis with anti-infectives in noncatheterized older nursing home residents to be implemented in the Improving Outcomes of UTI Management in Long-Term Care Project (IOU) funded by the Agency for Healthcare Research and Quality. DESIGN: Two-round modified Delphi survey. PARTICIPANTS: Expert panel of 19 clinical pharmacists. MEASUREMENTS: Comprehensive literature search and development/review/edit of draft survey by the investigative group (one geriatric clinical pharmacist, two geriatric medicine physicians, and one infectious disease physician). The expert panel members rated their agreement with each of 31 recommendations for drugs of choice, dosing medications at various levels of renal function, drug-drug interactions to avoid, and duration of therapy by sex on a 5-point Likert scale (1 = strongly disagree to 5 = strongly agree). Consensus agreement was defined as a lower 95% confidence limit of 4.0 or higher for the recommendation-specific mean score. RESULTS: The response rate was 95% for the first round, and three recommendations achieved consensus (dosing for nitrofurantoin and trimethoprim/sulfamethoxazole in those without chronic kidney disease, and drug-drug interaction between trimethoprim/sulfamethoxazole and warfarin). In the second round, 90% responded and reached consensus on an additional eight recommendations (two for nitrofurantoin or trimethoprim/sulfamethoxazole as initial drugs of choice, three for dosing ciprofloxacin, nitrofurantoin, and trimethoprim/sulfamethoxazole at various levels of chronic kidney disease, and three drug-drug interactions to avoid: trimethoprim/sulfamethoxazole with phenytoin and ciprofloxacin with theophylline or with tizanidine). CONCLUSION: An expert panel of clinical pharmacists was able to reach consensus on a set of recommendations for the empirical treatment of cystitis with oral anti-infective medications in older nursing home residents. The recommendations were incorporated into a treatment algorithm for uncomplicated cystitis in noncatheterized nursing home residents and used in educational materials for health professionals in an ongoing controlled intervention study. J Am Geriatr Soc 67:539-545, 2019.
Authors: Kevin P High; Suzanne F Bradley; Stefan Gravenstein; David R Mehr; Vincent J Quagliarello; Chesley Richards; Thomas T Yoshikawa Journal: Clin Infect Dis Date: 2009-01-15 Impact factor: 9.079
Authors: Christine E Kistler; Sheryl Zimmerman; Kezia Scales; Kimberly Ward; David Weber; David Reed; Mallory McClester; Philip D Sloane Journal: J Am Geriatr Soc Date: 2017-03-28 Impact factor: 5.562
Authors: Jacques Baillargeon; Holly M Holmes; Yu-Li Lin; Mukaila A Raji; Gulshan Sharma; Yong-Fang Kuo Journal: Am J Med Date: 2012-02 Impact factor: 4.965
Authors: M Loeb; D W Bentley; S Bradley; K Crossley; R Garibaldi; N Gantz; A McGeer; R R Muder; J Mylotte; L E Nicolle; B Nurse; S Paton; A E Simor; P Smith; L Strausbaugh Journal: Infect Control Hosp Epidemiol Date: 2001-02 Impact factor: 3.254
Authors: David A Nace; Joseph T Hanlon; Christopher J Crnich; Paul J Drinka; Steven J Schweon; Gulsum Anderson; Subashan Perera Journal: JAMA Intern Med Date: 2020-07-01 Impact factor: 21.873
Authors: Joseph T Hanlon; Subashan Perera; Steven Schweon; Paul Drinka; Christopher Crnich; David A Nace Journal: J Am Med Dir Assoc Date: 2020-09-16 Impact factor: 4.669
Authors: Cara L Grimes; Ethan M Balk; Catrina C Crisp; Danielle D Antosh; Miles Murphy; Gabriela E Halder; Peter C Jeppson; Emily E Weber LeBrun; Sonali Raman; Shunaha Kim-Fine; Cheryl Iglesia; Alexis A Dieter; Ladin Yurteri-Kaplan; Gaelen Adam; Kate V Meriwether Journal: Int Urogynecol J Date: 2020-04-27 Impact factor: 2.894